# Regulation of Lipoprotein Transport in Metabolic Syndrome

> **NCT00841217** · PHASE4 · COMPLETED · sponsor: **The University of Western Australia** · enrollment: 13 (actual)

## Conditions studied

- Obesity
- Lipid Disorders
- Cardiovascular Disease

## Interventions

- **DRUG:** GW501516
- **DRUG:** placebo pill

## Key facts

- **NCT ID:** NCT00841217
- **Lead sponsor:** The University of Western Australia
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-04
- **Primary completion:** 2005-08
- **Final completion:** 2008-12
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2009-02-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00841217

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00841217, "Regulation of Lipoprotein Transport in Metabolic Syndrome". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT00841217. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*